Company Active LTD

Company profile

Mindspire Limited

MindSpire: Feel the power of vagus nerve stimulation Mindspire

We harness the power of the vagus nerve to activate specific brain areas & communicate to the body, to build resilience, boost performance & treat chronic conditions. Our mission is to empower individuals to take charge of their lives and think differently. Sign up to our newsletters for the latest science & offers.

CRN
11649630
Founded
2018
Age
7

Overview

Legal name
MINDSPIRE LIMITED
Region
South East England
Registered address
NAPIER HOUSE
14-16 MOUNT EPHRAIM ROAD
TUNBRIDGE WELLS
UNITED KINGDOM
TN1 1EE
Insolvency history
No

Latest accounts

Financial period: 1 Nov 2024 to 31 Oct 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Jul
2027

Accounts due

Accounts Due

Next accounts due date

19 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

05 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Oct
2025

Accounts filed

Accounts

Last accounts made up date

30 Oct
2018

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2020
Funded years
2020, 2024, 2025
Age at first award
1 years

Projects

2025 Investment Accelerator Lead participant

Advancing Immersive Audio Therapy for Anxiety Disorders

1 Feb 2025 to 31 Jan 2026

Awarded
£337,297
Total cost £749,549

Anxiety disorders are among the most common mental health conditions worldwide, affecting approximately 264 million people globally. In the UK alone, it is estimated that one in six people will experience a common mental health problem, such as anxiety or depression, in any given week. Anxiety disorders can significantly impair an individual's ability to ...

2024 Collaborative R&D Lead participant

VR THERAPY + CLOSE LOOP VAGUS STIMULATION

1 Jul 2024 to 28 Feb 2026

Awarded
£40,384
Total cost £57,691

Rescape has been deploying immersive therapies to treat patients' pain and anxiety for over 4 years with a class 1 medical device called DR.VR(r) - we have already licenced our solution to over 80 NHS locations. Our project innovation will combine closed-loop Vagus Nerve Stimulation with Virtual Reality therapies to amplify the benefits of both treatments...

2024 Collaborative R&D Lead participant

MindSpire: Pioneering Bioelectronic Precision Medicine

1 Apr 2024 to 31 Dec 2024

Awarded
£98,912
Total cost £98,912

This project will see MindSpire's highly innovative bioelectronic headset for personalised vagus nerve stimulation move one step closer to market. The project starts with the final testing of electrode materials and locations on the ear before moving on to consolidate past hardware and software innovations into a unified, functional prototype for real tim...

2020 Feasibility Studies Lead participant

Early detection of coronavirus infection using Heart Rate Variability

1 Jun 2020 to 28 Feb 2021

Awarded
£73,590
Total cost £73,590

MindSpire proposes an easy to adopt early biomarker of the Coronavirus infection that can be detected days before symptoms appear. The use of Heart Rate Variability (HRV), a measure of the variation in time between each heartbeat, reflects the ability of the heart to respond to different situations and can react to stress or illness before any changes in ...

Product types

Collaborative R&D Feasibility Studies Investment Accelerator